Receptorium adrenergicum alpha 2 (Latin Wikipedia)

Analysis of information sources in references of the Wikipedia article "Receptorium adrenergicum alpha 2" in Latin language version.

refsWebsite

Global rank Latin rank

4^th place

12^th place

nih.gov

pubmed.ncbi.nlm.nih.gov

Knaus A. E., Muthig V., et al. (Oct 2007). "Alpha2-adrenoceptor subtypes--unexpected functions for receptors and ligands derived from gene-targeted mouse models". Neurochemistry international 51 (5): 277-81
Che P., Chen Y., et al. (Aug 2015). "Spinophilin Is Indispensable for the α2B Adrenergic Receptor-Elicited Hypertensive Response". PLoS One 10 (8): e0135030 vel fluxus
Hurt C. M., Feng F. Y., Kobilka B. (Nov 2000). "Cell-type specific targeting of the alpha 2c-adrenoceptor. Evidence for the organization of receptor microdomains during neuronal differentiation of PC12 cells". The journal of biological chemistry 275 (45): 35424-31
Filipeanu C. M., Pullikuth A. K., Guidry J. J. (Mai 2015). "Molecular determinants of the human α2C-adrenergic receptor temperature-sensitive intracellular traffic". Molecular pharmacology 87 (5): 792-802
Vanhoutte P. M. (Nov 2001). "Endothelial adrenoceptors". Journal of cardiovascular pharmacology 38 (5): 7096-808
Berridge C. W., Spencer R. C. (Iun 2016). "Differential cognitive actions of norepinephrine a2 and a1 receptor signaling in the prefrontal cortex". Brain research 1641 (Pt B): 189-96
Arnsten A. F., Dudley A. G. (Apr 2005). "Methylphenidate improves prefrontal cortical cognitive function through alpha2 adrenoceptor and dopamine D1 receptor actions: Relevance to therapeutic effects in Attention Deficit Hyperactivity Disorder". Behavioral and brain functions 1 (1): 2
Kanagy N. L. (Nov 2005). "Alpha(2)-adrenergic receptor signalling in hypertension". Clinical science 109 (5): 431-7
Flordellis C., Manolis A., et al. (Dec 2004). "Clinical and pharmacological significance of alpha2-adrenoceptor polymorphisms in cardiovascular diseases". International journal of cardiology 97 (3): 367-72
Nguyen V., Tiemann D., et al. (Iun 2017). "Alpha-2 Agonists". Anesthesiology clinics 35 (2): 233-45
Muzyk A. J., Fowler J. A., et al. (Mai 2011). "Role of α2-agonists in the treatment of acute alcohol withdrawal". The annals of pharmacotherapy 45 (5): 649-57
Mantz J., Josserand J., Hamada S. (Ian 2011). "Dexmedetomidine: new insights". European journal of anaesthesiology 28 (1): 3-6
Alamo C., López-Muñoz F., Sánchez-García J. (Mai 2016). "Mechanism of action of guanfacine: a postsynaptic differential approach to the treatment of attention deficit hyperactivity disorder (adhd)". Actas espanolas de psiquiatria 44 (3): 107-12